ISTAART NPS PIA day at AAIC 2017 – ISCTM session
Addressing the challenges in treating apathy associated with Alzheimer's disease
15 July, 2017 // London, England
How do we get the pharmaceutical industry off the couch? | David Miller, MD![]() |
Overcoming challenges in developing pharmacotherapies for NPS: Apathy in Alzheimer’s disease | Krista Lanctôt, PhD![]() |
Examining the neurocircuity of apathy and markers of neurodegenertion in early Alzheimer’s disease | Gad Marshall, MD![]() |
Treatment of apathy in psychiatric and neurodegenerative disorders: Are positive valence systems of reward shared in control | Larry Ereshefsky, PharmD![]() |